Sexually Transmitted Diseases Vaccines, Prevention, and Control

Praise for the previous edition:
"...presents an abundance of information that provides a clear understanding of sexually transmitted pathogens, factors that must be addressed in efforts to control the spread of disease, and the state of research on barrier methods of prevention and vaccines. ...it will be important reading for students, scientists, and public health practitioners, providing guidance on how best to use the tools we have today while clearly describing the tools needed to complete the armamentarium and the road toward their development." --David L. Heymann, World Health Organization, in THE NEW ENGLAND JOURNAL OF MEDICINE (April 2001)

"...the book comprehensively presents the important pathogens of sexually transmitted infections and the research aimed at developing vaccines against them. Past and recent vaccine strategies, current state of vaccine development and their future prospects are discussed in different chapters with great care and sincerity...This book is useful and important reading for those interested in infectious diseases and their prevention, control and vaccine development." --S. Das in THE JOURNAL OF MEDICAL MICROBIOLOGY (April 2001)

"very useful and comprehensive information for clinicians, microbiologists and virologists interested in pathogenesis and prevention of STD." --ACTA VIROLOGICA

Drs. Stanberry and Barrett are highly respected authorities in vaccine development. Dr. Barrett researches tropical virus diseases such as dengue, West Nile, yellow fever and Japanese encephalitis. He has made important contributions to molecular aspects of immunogens and preclinical development of candidate vaccines for these diseases, and studies on the current yellow fever 17D vaccine. Dr Stanberry focuses on sexually transmitted diseases research and has made important contributions in the area of tropical microbicides an in herpes simplex virus pathogenesis, immunobiology, and antiviral therapy. He has played major roles in the pre-clinical and clinical assessment of many of the herpes vaccines currently in development.